Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1490601
                    [Title] => Earliest breast cancer risky for some women, study suggests
                    [Summary] => 
New research shows that chances of dying from very early breast cancer are small but the disease is riskier for young women and blacks, the same disparities seen for more advanced cancer.

                    [DatePublished] => 2015-08-20 17:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1462217
                    [AuthorName] => Lindsey Tanner
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://media.philstar.com/images/the-philippine-star/world/20150821/Breast-Cancer-Mammography-Image.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 588820
                    [Title] => Roche drug helps women with ovarian cancer live longer
                    [Summary] => 
Roche recently announced results from a Phase III study of bevacizumab that showed women with previously untreated advanced ovarian cancer who received bevacizumab in combination with chemotherapy, followed by the continuation of bevacizumab alone, had a 39 percent improvement in the likelihood of living longer without the disease worsening (progression-free survival or PFS) compared to chemotherapy alone.
                    [DatePublished] => 2010-07-01 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

FOX CHASE CANCER CENTER

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1490601
                    [Title] => Earliest breast cancer risky for some women, study suggests
                    [Summary] => 
New research shows that chances of dying from very early breast cancer are small but the disease is riskier for young women and blacks, the same disparities seen for more advanced cancer.

                    [DatePublished] => 2015-08-20 17:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1462217
                    [AuthorName] => Lindsey Tanner
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://media.philstar.com/images/the-philippine-star/world/20150821/Breast-Cancer-Mammography-Image.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 588820
                    [Title] => Roche drug helps women with ovarian cancer live longer
                    [Summary] => 
Roche recently announced results from a Phase III study of bevacizumab that showed women with previously untreated advanced ovarian cancer who received bevacizumab in combination with chemotherapy, followed by the continuation of bevacizumab alone, had a 39 percent improvement in the likelihood of living longer without the disease worsening (progression-free survival or PFS) compared to chemotherapy alone.
                    [DatePublished] => 2010-07-01 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Earliest breast cancer risky for some women, study suggests

By Lindsey Tanner | August 20, 2015 - 5:00pm

New research shows that chances of dying from very early breast cancer are small but the disease is riskier for young women...

Health And Family

Roche drug helps women with ovarian cancer live longer

July 1, 2010 - 12:00am

Roche recently announced results from a Phase III study of bevacizumab that showed women with previously untreated advanced ovarian cancer who received bevacizumab in combination with chemotherapy, followed by the...

Science and Environment